IP Verse

Drries competitive analysis

Latest oppositions filed by Drries

Explore patent oppositions filed by Drries against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP3423067
Compositions And Methods For Muscle Regeneration Using Prostaglandin E2THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYApr 22, 2026
EP3313373
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025
EP3824879
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025
EP3684786
Mutated Glycoprotein Of Vesicular Stomatitis VirusCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSMay 14, 2025
EP3227447
Guide Rna With Chemical ModificationsAGILENTJan 22, 2025
EP4069368
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025
EP3110848
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 13, 2024
EP3515465
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 7, 2024
EP3791896
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerASTELLAS PHARMAOct 10, 2024
EP3973987
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 1, 2024

Latest PTAB cases involving Drries

Discover the latest PTAB cases involving Drries, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Drries with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DRRIES10 - - -
ALTEOGEN - 11 - 1
REGENERON PHARMACEUTICALS38121932
SANOFI BIOTECHNOLOGY - 66 - -